Results 161 to 170 of about 1,701 (232)

Development and validation of a method for quantitative determination of the genotoxic impurity diethyl sulfate in pitolisant hydrochloride <i>via</i> high-performance liquid chromatography. [PDF]

RSC Adv
Bhagwat S, Patil P, Pawar R, Shinde S, Amalnerkar D, Shinde D.   +5 more
europepmc   +1 more source

Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Residual Sleepiness in Obstructive Sleep Apnea Despite Continuous Positive Airway Pressure: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. [PDF]

CNS Drugs
Tanayapong P, Tantrakul V, Liamsombut S, Siriyotha S, McKay G, Attia J, Thakkinstian A.   +6 more
europepmc   +1 more source

Obstructive Sleep Apnoea Treatments-Where Are We Now? [PDF]

Respirology
Luu S, Lee D, Yee BJ.
europepmc   +1 more source

Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development. [PDF]

Transl Psychiatry
Le Foll B, Naassila M, Jeanblanc J, Hendershot CS, Chavarria J, Calmels T, Krief S, Berrebi-Bertrand I, Uguen M, Perrin D, Ligneau X, Boileau I, Rusjan PM, Di Ciano P, Sabioni P, Capet M, Robert P, Finance O, Lecomte JM, Schwartz JC.   +19 more
europepmc   +1 more source

Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study. [PDF]

J Sleep Res
Dauvilliers Y, Craig SE, Bonsignore MR, Barbé F, Verbraecken J, Asin J, Georgiev O, Tiholov R, Caussé C, Lecomte JM, Schwartz JC, Lehert P, Randerath W, Pépin JL, HAROSA III Study Group.   +14 more
europepmc   +1 more source

Trends and variation in issuance of high-cost narcolepsy drugs by NHS England organisations and regions from 2019 to 2022. [PDF]

J Sleep Res
van Someren F, Wiedemann M, Warren-Gash C, Sykorova M, Mistry H, Miller MA, Leschziner G, Nolte E, Belot A, Smith IE, Quinnell T, Eriksson SH, Strongman H.   +12 more
europepmc   +1 more source

Comparaison du profil de sécurité du pitolisant et du solriamfétol : revue systématique et méta-analyse

Toth, Rémi
openalex   +1 more source

Treatment paradigms for cataplexy in narcolepsy: past, present, and future [PDF]

core   +2 more sources

Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/Inverse Agonist Pitolisant in Prader-Willi Syndrome. [PDF]

Psychopharmacol Bull
Freitas B, Teodoro TP.
europepmc   +1 more source